This research specifically focused on people with type 2 diabetes, so more research is needed in other groups, and the results should not be generalized
These products are not FDA-approved, have not been reviewed by FDA for safety and effectiveness, and FDA cautions they can lead to serious and potentially life-threatening adverse health consequences including infections and sepsis. Knock-off versions of semaglutide pose significant threats to peoples health and safety, a Novo Nordisk spokesperson said in an email to Healio | Endocrine Today
Lixisenatide Adlyxin (Injection) Indication : Type 2 Diabetes
Related Reading Temporary Glp 1 Provider While Prior Authorization Pending Plexusdx Sprout Health Glp 1 Review Plexusdx Can A Dna Test Reveal If I Will Benefit From Glp 1 Medications Maximus Glp 1 Medical and Editorial Standards Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims
Side effects and gaps in follow-up care are also causing disruptions in medication use, according to CHOPs findings, recently published in the journal Pediatrics